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Abstract
Background: Imipramine, a tricyclic antidepressant widely used clinically, has other pharmacological effects, such as
antileishmanial activity. Tricyclic antidepressants interact with lipid bilayers, and some studies have shown that imipramine
inhibits methyltransferases. Leishmania spp. produces compounds with an ergostane skeleton instead of a cholesterol
skeleton, and the inhibition of enzymes of the sterol biosynthesis pathway is an interesting therapeutic target.
Among these enzymes, C-24 methyltransferase has been suggested to play an essential role, as its inhibition kills
the parasites. In this context, we investigated whether imipramine alters the biosynthesis of sterols in L. amazonensis
and evaluated the efficacy of imipramine alone and in combination with miconazole, a classical inhibitor of another
step in this pathway.
Methods: To analyze the interference of imipramine with sterol metabolism, promastigotes of L. amazonensis were
cultured with medium alone, 15 or 30 μM imipramine or 4 μM miconazole, and their lipids were extracted with
methanol/chloroform/water (1:0.5:0.4 v/v) and analyzed by GC/MS. To assess the antileishmanial activity of the
treatments, promastigotes of L. amazonensis were incubated with various concentrations of imipramine up to
100 μM and up to 24 μM miconazole. Promastigotes were also treated with the combination of imipramine and
miconazole at concentrations up to 12.5 μM of imipramine and 24 μM of miconazole. Parasite growth was evaluated
by the MTT assay. The fractional inhibitory concentration index (FICI) was calculated to determine whether there were
synergistic effects. Peritoneal macrophages with and without L. amazonensis infection were treated with miconazole
(0 – 16 μM) or imipramine (0 to 50 μM) for 72 hours. For assays of the combined treatment in amastigotes, the
concentration of imipramine was fixed at 12.5 μM and various concentrations of miconazole were used up to 16 μM.
The infection rate was determined by counting the infected macrophages under a light microscope.
Findings: Promastigotes treated with imipramine accumulated cholesta-5,7,22-trien-3β-ol and cholesta-7-24-dien- 3β-ol,
sterols that normally increase after treatment with classical inhibitors of C-24 methyltransferase. The IC50 of miconazole in
promastigotes decreased when it was used in combination with imipramine, resulting in an additive effect, with a FICI
value of 0.83. Imipramine also showed activity against intracellular amastigotes and enhanced the activity of miconazole,
without apparent toxicity to the host cells.
Conclusions: Imipramine was confirmed to have antileishmanial activity in both forms of the parasite, affecting the sterol
biosynthesis of the organisms. Using imipramine in combination with azoles may be advantageous for the treatment of
leishmaniasis.
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Background
Leishmaniasis is a disease caused by parasites of the genus
Leishmania, unicellular eukaryotes belonging to class
Kinetoplastea and family Trypanosomatidae. Leishmania
spp. are transmitted by more than 20 species of sandflies
of the genera Phlebotomus and Lutzomyia [1]. Leishmania-
sis is a non-contagious infectious disease that can affect
the skin and mucous membranes (cutaneous leishmania-
sis) or internal organs (visceral leishmaniasis) [2, 3]. En-
demic transmission of leishmaniasis is known to occur in
98 countries on five continents. It has been estimated that
there were more than 58,000 cases of visceral leishmania-
sis and 220,000 cases of cutaneous leishmaniasis [4].
Since the 1940s, the main treatment for leishmaniasis
has included antimony derivatives that are commercially
available in two formulations, N - methylglucamine anti-
moniate (meglumine antimoniate, Glucantime®) and so-
dium stibogluconate (Pentostam®) [5]. These drugs have
many toxic effects, including cardiac, hepatic, pancreatic
and renal toxicity, and should be used with caution and
with clinical and laboratory monitoring in patients with
heart or liver disease [6]. The efficiency of antimony may
vary, and treatment protocols are determined depending
on the region. Many cases of resistance have been re-
ported, making treatment difficult [7]. Miltefosine, the
only oral treatment, has been prescribed in India for
visceral leishmaniasis for more than a decade and was
recently approved by the FDA for all forms of this dis-
ease, but some concerns about resistance and terato-
genicity have been raised [8, 9]. Other drugs, such as
pentamidine and amphotericin B, may be used if resist-
ance to the first-line treatment occurs, although these
have major toxicity [5]. Furthermore, no vaccine for
human use has been developed to date, although some
studies have been carried out, such as a study of the
protective role of serine proteases in the parasite [10].
Thus, there is a need to search for new strategies to
control leishmaniasis.
Imipramine, a tricyclic antidepressant widely used in the
clinical setting, is used in the treatment of severe chronic
depression because it inhibits5-hydroxytryptamine (sero-
tonin) and norepinephrine reuptake [11]. Beyond its ac-
tions on the central nervous system, imipramine also has
other biological effects, such as immunosuppressive prop-
erties through the modulation of inflammatory cytokine
production and the induction of autophagic death in tumor
cells [12, 13]. The antileishmanial effects of imipramine
and its analogs were first demonstrated in the 1980s in
promastigotes and amastigotes of L. donovani and L.
major [14]. Imipramine also exhibited activity against
antimony-resistant intracellular amastigotes without af-
fecting the host cells. Additionally, oral treatment with
imipramine reduced the parasite burden of visceral
leishmaniasis in hamsters [15].
Tricyclic antidepressants have high affinity for the
phosphatidylcholine and phosphatidylethanolamine in
lipid membranes, causing changes in lipid-protein in-
teractions [16]. Another interesting feature of imipra-
mine is its effect on methyltransferases. Imipramine
has been described to inhibit the activity of catechol-
O-methyltransferase (COMT), DNA methyltransferase
and the methylation of phospholipids in the plasma
membrane [17, 18].
The sterol biosynthesis pathway of trypanosomatids has
diverged from that in mammalians such that these para-
sites produce ergosterol derivatives instead of cholesterol
[19]. It is assumed that this biosynthetic pathway is essen-
tial in Leishmania because pharmacological inhibition of
different steps results in the death of the parasite [20–25].
Methylation by C-24methyltranferase is one of final steps
of sterol biosynthesis in Leishmania, and this reaction
does not occur in mammalians. Inhibition of this enzyme
by azasterols causes the accumulation of cholestane deriv-
atives and leads to parasite death [26].
Here we investigated the effects of imipramine on the
sterol biosynthesis of L. amazonensis and its leishmani-
cidal activity in combination with miconazole, a well-
known inhibitor of this pathway.
Methods
Drugs
Miconazole and imipramine were provided by Sigma–
Aldrich (St. Louis, USA) and stored at -20o C in DMSO
(Sigma-Aldrich) stock solution (10 mM).
Maintenance and cultivation of parasites
Promastigotes of Leishmania amazonensis (strain MHOM/
BR/77/LTB0016) were maintained at 26 °C in RPMI
medium (Sigma- Aldrich) supplemented with 10 % fetal
bovine serum (FBS), 100 μg/ml streptomycin, 100 U/ml
penicillin and 5 mg/ml hemine. Subcultures were per-
formed twice a week until the tenth passage. Afterwards,
old cultures were discarded and fresh parasites were ob-
tained from infected BALB/c mice.
Antipromastigote activity
Promastigotes of L. amazonensis were maintained in cell
culture flasks at 26 °C in RPMI medium without phenol
red (Sigma- Aldrich) supplemented as described above.
Experiments were performed on promastigotes in 96-well
plates, with an initial inoculum of 1.0 × 106cells/ml and
compound concentrations of up to 24 μM of miconazole
and to 100 μM of imipramine. In the combination experi-
ments, the concentrations were up to 24 μM of micona-
zole and 12.5 μM of imipramine. Plates were incubated at
26 °C for 72 hours. After this period, parasite growth was
evaluated by adding 10 % tetrazolium salt (MTT, Sigma-
Aldrich) (5 mg/ml) per well. The plates were incubated at
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26 °C for a further hour, and formazan crystals were
dissolved by adding 80 μl of DMSO to each well. The re-
action was analyzed using a spectrophotometer at 570 nm
wavelength. IC50 values were obtained by non-linear re-
gression using the GraphPad Prism 6 software (GraphPad
Software Inc., La Jolla, USA). The fractional inhibitory
concentration (FIC) determined to analyze whether the
combination treatments were synergistic was calculated as
follows: FIC = IC50 of drug A in combination/IC50 of drug
A alone + IC50 of drug B in combination/IC50 of drug B
alone. The arithmetic mean of the FICs obtained for each
concentration was interpreted according to published
guidelines: synergy (FIC ≤ 0.5), antagonism (FIC ≥ 4.0) and
additive effect (no interaction) (0.5 < FIC < 4.0) [27].
Antiamastigote activity
Peritoneal macrophages from BALB/c mice were infected
with promastigotes of L. amazonensis in Lab-Tek cham-
bers (Nunc, Roskilde, Denmark) and kept at 37 °C. After
four hours, the chambers were washed, and the cultures
were treated with miconazole alone or in combination
with imipramine in supplemented RPMI medium for
72 hours. Various concentrations were used for these
studies, with up to 16 μM of miconazole and 50 μM of
imipramine. In the combination assays, the concentration
of imipramine was fixed at 12.5 μM and the concentration
of miconazole varied, with the maximum concentration
being 16 μM. After incubation, the slides were stained,
and the infection rate was determined by counting the in-
fected macrophages under a light microscope. The infec-
tion rate was calculated using the formula: % infected
macrophages × number of amastigotes/number of total
macrophages.
Toxicity to macrophages
Mouse peritoneal macrophages in 96-well plates were
treated with imipramine and miconazole alone or in com-
bination for 72 hours at 37 °C. After this period, the cell
viability was evaluated by adding 10 % tetrazolium salt
(MTT) (5 mg/ml) to each well. The plates were incubated
at 37 °C for another four hours, and the resulting forma-
zan crystals were dissolved by adding 80 μl DMSO to each
well. The plates were then read at 570 nm. The results
were expressed as the percentage of viable cells compared
to the untreated control.
Extraction of lipids
Lipids from promastigotes of L. amazonensis were ex-
tracted using the method reported by Bligh & Dyer [28].
Briefly, samples were pelleted, and a solution of methanol,
chloroform and water (2:1:0.5 v/v) was added. After stirring
the mixture for one hour, the samples were centrifuged for
20 min at 3,000 rpm and the supernatant containing the
lipids was separated from the precipitate. The precipitate
was subjected to a second extraction under the same con-
ditions. The supernatants were combined, and methanol/
chloroform/water (1:0.5:0.4 v/v) was added. After 40 sec-
onds of stirring, the material was centrifuged (3,000 rpm/
30 min) again. The lower layer (organic) containing the
lipids was then separated with the aid of a glass syringe
and was transferred to a 1.5 ml tube resistant to organic
solvents (Axygen Scientific, Inc., Union City, CA, USA).
The solvent was evaporated under an N2 flux, and the
lipids were analyzed by gas chromatography- mass spec-
trometry (GC/MS), as described below.
Analysis of the sterol profile by gas chromatography
coupled with mass spectrometry (GC/MS)
Promastigotes of L. amazonensis were cultured with 15 or
30 μM imipramine or 4 μM miconazole or in culture
medium alone. After 72 hours, 1×108 parasites from each
culture were washed three times in cold PBS (pH 7.5), and
the sterols were extracted as described in Section 3.6. The
samples were injected into a GC/MS - QP2010 Ultra Ma-
chine (Shimadzu Scientific Instruments, Tokyo, Japan).
After injection, the column temperature was maintained
at 50 °C for one minute and then increased to 270 °C at a
rate of 10 °C/min and finally to 300 °C at a rate of 1 °C/
min. The flow of the carrier gas (He) was kept constant at
1.1 ml/min. The temperatures of the injector and detector
were 250 °C and 280 °C, respectively [29].
Ethical approval
Macrophages from BALB/c mice were obtained in ac-
cordance with protocols approved by the Ethics Com-
mittee for Animal Use of the Instituto Oswaldo Cruz
(L026/2015).
Results and discussion
Imipramine has effects on the cell growth and mem-
brane functions of L. donovani and L. major [14]. Anti-
depressants cause lethal disruption of their membrane
function, reductions in mitochondrial proton motive
force and apoptosis in Leishmania spp. [30]. In addition
to the effects on the parasite itself, imipramine is also a
potent inducer of TNF-α in macrophages, which is an
important cytokine for antileishmanial defense [31]. Tricyc-
lic antidepressants (imipramine, desipramine, amitriptyline
and nortriptyline) are amphiphilic molecules that accumu-
late in membranes and alter their biophysical characteristics
[16, 32]. Imipramine has also been demonstrated to inhibit
the three main classes of methyltransferases (N, O and C-
methyltransferases). The activity of phosphatidylethanol-
amine N-methyltransferase was also found to be inhibited
by imipramine and chlorpromazine [33]. Moreover, imipra-
mine has inhibitory effects on erythrocyte catechol-O-
methyltransferase and indirectly inhibits DNA methylation
by cytosine C-methyltransferase [17, 34].
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Table 1 Effects of imipramine and miconazole on the sterol composition of L. amazonensis promastigotes
C Imipramine 15 μM Imipramine 30 μM Miconazole 4 µM
Substance PM Relative amount (%)
(1) Cholesterol (exogenous)
386 9.49 7,76 5,4 15.04
(2) Cholesta-5,7,22-trien-3β-ol
382 - 28,1 40,33 -
(3) Cholesta-7-24-dien- 3β-ol
384 - 2,45 4,11 -
(4) 14α-metilergosta-8,24 (241)-dieno-3β-ol
412 - - - 46.40
(5) Ergosta-5,7,24-trien-3β-ol (dehydroepisterol)
396 83,4 56,07 48,67 4.15
(6) Ergosta-7,24-dien-3β-ol (Episterol)
398 7,1 5,62 1,49 -
(7) 4α,14α-dimetilergosta-8,24 (241)-dieno-3β-ol(Obtusofoliol)
426 - - - 34.41
C – Untreated control
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Considering the affinity of imipramine for membranes
and its effects on methyltransferases, we hypothesized
that imipramine may interfere with the sterol metabol-
ism of parasites. Therefore, we analyzed the sterol com-
position of promastigotes of L. amazonensis when they
were exposed to imipramine. Table 1 shows the results
of an analysis of the relative amount of each sterol. The
promastigotes treated with imipramine showed a decrease
in cholesterol (1) and in the ergostane-derived sterols (C24-
methylated sterols) ergosta-5,7,24-trien-3β-ol (dehydroepis-
terol) (5) and ergosta-7,24-dien-3β-ol (episterol) (6).
Interestingly, we also observed a concomitant accumulation
of cholestane-derived sterols (C24-demethylated ste-
rols), cholesta-5,7,22-trien-3β-ol (2), cholesta-7-24-dien-
3β-ol (3).
Azasterols inhibit the C24 sterol methyltransferase,
an enzyme required for the production of the typical
ergostane- and stigmastane-based sterols, which are not
found in mammalian cells [35]. Azasterols interfere
with the sterol biosynthesis of T. cruzi and Leishmania
spp., resulting in cell growth arrest and death [36]. The
treatment of L. donovani promastigotes with azasterol
altered their sterol profile, leading to a global decrease
in 24-methylsterols and an increase in demethylated
sterols [37]. This effect is similar to that observed follow-
ing the treatment with imipramine (Table 2), suggesting
that it occurs via a similar mechanism of action.
Various inhibitors of sterol biosynthesis (azoles, sta-
tins and allylamines) have been extensively studied in
Leishmania spp., confirming that this pathway is an ex-
cellent target for the chemotherapy of leishmaniasis
[19, 21–25, 37, 38]. As seen in Table 1, treatment with mi-
conazole disturbs the sterol synthesis in a different fashion
than imipramine, causing the accumulation of C14 methyl
sterols, 14α-metilergosta-8,24 (241)-dieno-3β-ol (4) and
obtusofoliol (7), sterols that typically accumulate following
the inhibition of C14 demethylase [20].
Using a combination of drugs that act on different
points of the same pathway has been noted to represent
an interesting strategy for antimicrobial chemotherapy
[20, 21]. Haughan et al. demonstrated that the combin-
ation of lovastatin (an HMGCoA reductase inhibitor) and
miconazole (C14-demethylase inhibitor) led to synergistic
activity against promastigotes of L. amazonensis [23].
Therefore, since both drugs (imipramine and miconazole)
interfere with the sterol synthesis pathway, but generate
different aberrant metabolites, we decided to evaluate the
effects of their combination on the parasite growth. The
antileishmanial activity of imipramine alone and in com-
bination with miconazole in the promastigotes of L. ama-
zonensis is shown in Fig. 1a and b. The effects of the
combination were expressed graphically as an isobolo-
gram, where the IC50values of the drugs alone and in
combination were plotted. The fractional inhibitory
concentration index (FICI) was calculated to classify
the interaction as synergistic, antagonistic or additive.
As expected, miconazole was active against promasti-
gotes, with an IC50 of 4.7 ± 1.03 μM. Imipramine also
proved to be active alone, with an IC50 of 28.63 ±
1.2 μM. The combination resulted in an additive effect,
as observed in the isobologram, with a FICI value of
0.83 (Fig. 1b-c), suggesting that imipramine and micon-
azole can be used in combination, as no antagonistic
effect was observed.
Before testing the effects on intracellular amastigotes, we
evaluated the toxicity of imipramine alone and in combin-
ation with miconazole in host cells. Uninfected peritoneal
macrophages showed no signs of toxicity when incubated
with imipramine alone at concentrations less than 50 μM
(Fig. 2a). Miconazole also showed no toxic effects, even
when used in combination with imipramine (Fig. 2b-c).
In the next step, we assessed the activity of imipramine
against intracellular amastigotes, the clinically significant
stage of the parasite. The IC50 was found to be 13.32 ±
1.1 μM (Fig. 3a). Due to the experimental difficulty asso-
ciated with performing a “checkerboard” approach to
draw isobolograms for antiamastigote activity, we fixed
the concentration of imipramine at 12.5 μM and varied
the concentration of miconazole to calculate the IC50
and IC90 values of the combination. When used in com-
bination with imipramine, the IC50 of miconazole was
reduced from 2.2 ± 0.2 μM to 0.5 ± 0.1 μM and the IC90
was reduced from 3.9 ± 0.2 μM to 2.2 ± 0.1 μM (Fig. 3b).
In addition to having its own machinery for sterol
biosynthesis, Leishmania also uptakes a significant
amount of exogenous cholesterol, mainly through the
endocytosis of LDL particles [39]. Andrade-Neto et al.
have described that the inhibition of the sterol pathway
in L. amazonensis increases the intake of cholesterol
from the culture medium [40]. Interestingly, imipra-
mine has been reported to block the release of choles-
terol from lysosomes in mammalian cells, especially
from the endocytosis of LDL particles, preventing its
distribution for use by the cell [41, 42]. Therefore, it
is possible that imipramine is interfering with both
the biosynthesis and utilization of exogenous sources
of sterols, so further studies are needed to address
this issue.
Table 2 Relative proportions of 24-methylated and 24-
demethylated sterols from L. amazonensis promastigotes
treated with imipramine
Imipramine
0 15 μM 30 μM
% 24-alkylated 90.51 61.69 50.16
% 24-nonalkylated 0 30.55 44.44
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Conclusion
In summary, we have demonstrated that imipramine
has antileishmanial activity, most likely by affecting
the sterol biosynthesis of the parasites. The combin-
ation of imipramine with miconazole can improve the
Fig. 2 Effect on the toxicity of inhibitors peritoneal macrophages.
Uninfected macrophages were incubated with imipramine, miconazole
alone or the combination of the two agents for 72 hours at 37 °C. After
this period, the cells were incubated with MTT for 1 hour at 37 °C,
and the absorbance was read at 570 nm. a imipramine, b miconazole
c 12.5 μM imipramine (IMP) +miconazole. The experiments were
performed in triplicate, n = 3
Fig. 1 Antipromastigote activity of imipramine, miconazole and their
combination. Promastigotes of L. amazonensis were incubated with
different concentrations of imipramine with or without miconazole
for 72 hours at 26 °C. a imipramine, b imipramine +miconazole c an
isobologram. Each plotted point in the isobologram is the IC50 of
the drugs alone or in combination. The straight line connecting the
individual IC50values represents the theoretical line of additivity.
The experiments were performed in triplicate, n = 3. The graphs
are representative of one experiment, and the standard deviations are
shown. The graphics and IC50 values were obtained using the GraphPad
Prism 4 software. * P< 0.05, ** P< 0.01, *** P <0.001
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antileishmanial activity. These findings suggest that
imipramine could be useful to treat leishmaniasis, par-
ticularly if used in combination with other inhibitors
of sterol biosynthesis.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All authors read and approved the final version of the manuscript. VVAN,
MMCC and ECTS conceived and designed the assays. VVAN and TMP
performed the experiments. VVAN, TMP, MMCC and ECTS analyzed the data.
VVAN and ECTS contributed to the writing of the manuscript.
Acknowledgments
TMP and ECTS are CNPq fellows. VVAN is a CAPES fellow. ECTS received a
grant from the Programa Estratégico de Apoio à Pesquisa em Saúde,
FIOCRUZ (PAPES/CNPq; grant 407680/2012-8).
Received: 21 February 2016 Accepted: 21 March 2016
References
1. Jhingran A, Chatterjee M, Madhubala R. Leishmaniasis: epidemiological
trends and diagnosis. In: Myler PJ, Fasel N, editors. Leishmania - After the
genome. USA: Caister Academic Press; 2008. p. 1–14.
2. Marra F, Chiappetta MC, Vincenti V. Ear, nose and throat manifestations of
mucocutaneous Leishmaniasis: a literature review. Acta Biomed. 2014;
85(1):3–7.
3. Neuber H. Leishmaniasis. J Dtsch Dermatol Ges. 2008;6:754–64.
4. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M;
WHO Leishmaniasis Control Team. WHO Leishmaniasis Control Team:
Leishmaniasis Worldwide and Global Estimates of Its Incidence. Plos One.
2012;7(5):e3567.
5. Sundar S, Chakravarty J. Leishmaniasis: an update of current
pharmacotherapy. Expert Opinion on Pharmacother. 2013;14:53–63.
6. Oliveira LF, Schubach AO, Martins MM, Passos SL, Oliveira RV, Marzochi MC,
Andrade CA. Systematic review of the adverse effects of cutaneous
leishmaniasis treatment in the New World. Acta Trop. 2011;118:87–96.
7. Singh N, Chatterjee M, Sundar S. The overexpression of genes of thiol
metabolism contribute to drug resistance in clinical isolates of visceral
leishmaniasis (kala azar) in India. Parasit Vectors. 2014;17:7–596.
8. Kesselheim AS, Maggs LR, Sarpatwari A. Experience with the priority review
voucher program for drug development. JAMA. 2015;314:1687–8.
9. Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo TP, Beijnen JH,
Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert
M, Dujardin JC. Increasing failure of Miltefosine in the treatment of Kala-azar
in Nepal and the potential role of parasite drug resistance, reinfection, or
noncompliance. Clin Infect Dis. 2013;56:1530–8.
10. de Matos Guedes HL, da Silva Costa BL, Chaves SP, de Oliveira Gomes DC,
Nosanchuk JD, De Simone SG, Rossi-Bergmann B. Intranasal vaccination
with extracellular serine proteases of Leishmania amazonensis confers
protective immunity to BALB/c mice against infection. Parasit Vectors.
2014;7:448.
11. Obonaga R, Fernández OL, Valderrama L, Rubiano LC, Castro Mdel M,
Barrera MC, Gomez MA, Gore Saravia N. Treatment failure and Miltefosine
susceptibility in dermal leishmaniasis caused by Leishmania subgenus
Viannia species. Antimicrob Agents Chemother. 2014;58(1):144–52.
12. Racagni G, Popoli M. The pharmacological properties of antidepressants.
Int Clin Psychopharmacol. 2010;25(3):117–31.
13. Kenis G, Maes M. Effects of antidepressants on the production of cytokines.
Int J Neuropsychopharmacol. 2002;5(4):401–12.
14. Jeon SH, Kim SH, Kim Y, Kim YS, Lim Y, Lee YH, Shin SY. The tricyclic
antidepressant imipramine induces autophagic cell death in U-87 MG
glioma cells. Biochem Biophys Res Commun. 2011;413(2):311–7.
15. Zilberstein D, Dwyer DM. Antidepressants cause lethal disruption of
membrane function in the human protozoan parasite Leishmania. Science.
1984;226(4677):977–9.
16. Mukherjee S, Mukherjee B, Mukhopadhyay R, Naskar K, Sundar S, Dujardin JC,
Das AK, Roy S. Imipramine is an orally active drug against both antimony
sensitive and resistant Leishmania donovani clinical isolates in experimental
infection. PLoS Negl Trop Dis. 2012;6(12):e1987.
17. Fisar Z. Interactions between tricyclic antidepressants and phospholipid
bilayer membranes. Gen Physiol Biophys. 2005;24(2):161–80.
18. Zimmermann N, Zschocke J, Perisic T, Yu S, Holsboer F, Rein T.
Antidepressants inhibit DNA methyltransferase 1 through reducing G9a
levels. Biochem J. 2012;448(1):93–102.
19. Ahyayauch H, Bennouna M. Interaction of chlorpromazine and imipramine
with model membranes. Therapie. 1999;54(5):585–8.
20. Roberts CW, McLeod R, Rice DW, Ginger M, Chance ML, Goad LJ. Fatty acid
and sterol metabolism: potential antimicrobial targets in apicomplexan and
trypanosomatid parasitic protozoa. Mol Biochem Parasitol. 2003;126:129–42.
21. Rodrigues JC, Attias M, Rodriguez C, Urbina JA, Souza W. Ultrastructural and
biochemical alterations induced by 22,26-azasterol, a delta(24(25))-sterol
methyltransferase inhibitor, on promastigote and amastigote forms of
Leishmania amazonensis. Antimicrob Agents Chemother. 2002;46(2):487–99.
22. Vannier-santos MA, Urbina JA, Martiny A, Neves A, de Souza W. Alterations
induced by the antifungal compounds Ketoconazole and Terbinafine in
Leishmania. J of Eukaryot Microbiol. 1995;42:337–46.
Fig. 3 Antiamastigote activity of the combination of imipramine and
miconazole. Peritoneal macrophages infected with L. amazonensis
that were left untreated or treated with imipramine and miconazole
were incubated for 72 hours at 37 °C. After incubation, the cells
were fixed and stained. The infection rate was calculated using the
formula: % infected MØ x number of amastigotes/total No. MØ.
a imipramine b miconazole + 12.5 μM imipramine. The experiments
were performed in triplicate, n = 3. The graphs are representative of
one experiment, and the standard deviations are shown. * P < 0.05,
** P < 0.01, *** P < 0.001
Andrade-Neto et al. Parasites & Vectors  (2016) 9:183 Page 7 of 8
23. Haughan PA, Chance ML, Goad LJ. Synergism In vitro of Lovastatin and
Miconazole as antileishmanial agents. Biochem Pharmacol. 1992;44:
2199–206.
24. Berman JD, Holz GG, Beach DH. Effects of Ketoconazole on growth and
sterol biosynthesis of Leishmania mexicana promastigotes in culture.
Mol Biochem Parasitol. 1984;12:1–13.
25. Macedo-Silva ST, Urbina JA, de Souza W, Rodrigues JC. In Vitro activity of
the antifungal azoles Itraconazole and Posaconazole against Leishmania
amazonensis. PLoS One. 2013;8(12):e83247.
26. Lorente SO, Rodrigues JC, Jiménez Jiménez C, Joyce-Menekse M, Rodrigues C,
Croft SL, Yardley V, de Luca-Fradley K, Ruiz-Pérez LM, Urbina J, de Souza
W, González Pacanowska D, Gilbert, LH. Novel azasterols as potential
agents for treatment of leishmaniasis and trypanosomiasis. Antimicrob
Agents Chemother. 2004;48(8):2937–50.
27. Odds FC. Synergy, antagonism, and what the chequerboard puts between
them. J Anticrob Chemother. 2003;52(1):1.
28. Bligh EG, Dryer MJ. A rapid method of total lipid extraction and purification.
Can J Biochem Physiol. 1959;37(8):911–3.
29. Torres-Santos EC, Sampaio-Santos MI, Buckner FS, Yokoyama K, Gelb M,
Urbina JA, Rossi-Bergmann B. Altered sterol profile induced in Leishmania
amazonensis by a natural dihydroxymethoxylated chalcone. J Antimicrob
Chemother. 2009;63:469–72.
30. Zilberstein D, Liveanu V, Gepstein A. Tricyclic drugs reduce proton motive
force in Leishmania donovani promastigotes. Biochem Pharmacol. 1990;
39(5):935–40.
31. Kubera M, Kenis G, Bosmans E, Kajta M, Basta-Kaim A, Scharpe S,
Budziszewska B, Maes M. Stimulatory effect of antidepressants on the
production of IL-6. Int Immunopharmacol. 2004;4(2):185–92.
32. Giraud F, Claret M, Bruckdorfer KR, Chailley B. The effects of membrane
lipid order and cholesterol on the internal and external cationic sites of
the Na + -K+ pump in erythrocytes. Biochim Biophys Acta. 1981;647(2):
249–58.
33. Melzacka M, Janczar L, Nocon H. The effects of imipramine on the
methylation of phosphatidylethanolamine (PE) in the cortical membranes of
Wistar rats. Biochem Pharmacol. 1993;46(3):449–53.
34. Hoo JJ, Noldt P, Beckermann WJ, Agarwal DP, Goedde HW. In vitro effect of
haloperidol, chlorpromazine, imipramine and lithium on the erythrocyte
catechol-O-methyltransferase. Arzneimittelforschung. 1982;32(6):681–3.
35. Haughan PA, Chance ML, Goad LJ. Effects of an azasterol inhibitor of sterol
24-transmethylation on sterol biosynthesis and growth of Leishmania
donovani promastigotes. Biochem J. 1995;308:31–8.
36. Gigante F, Kaiser M, Brun R, Gilbert IH. SAR studies on azasterols as potential
anti-trypanosomal and anti-leishmanial agents. Bioorg Med Chem.
2009;17(16):5950–61.
37. Magaraci F, Jimenez CJ, Rodrigues C, Rodrigues JC, Braga MV, Yardley V,
de Luca-Fradley K, Croft SL, de Souza W, Ruiz-Perez LM, Urbina J, Gonzalez
Pacanowska D, Gilbert IH. Azasterols as inhibitors of sterol 24-
methyltransferase in Leishmania species and Trypanosoma cruzi. J Med
Chem. 2003;46(22):4714–27.
38. Medina JM, Rodrigues JCF, De Souza W, Atella GC, Barrabin H. Tomatidine
promotes the inhibition of 24-alkylated sterol biosynthesis and
mitochondrial dysfunction in Leishmania amazonensis promastigotes.
Parasitology. 2012;139:1253–65.
39. Bastin P, Stephan A, Raper J, Saint-Remy JM, Opperdoes FR, Courtoy PJ.
An M(r) 145,000 low-density lipoprotein (LDL)-binding protein is conserved
throughout the Kinetoplastida order. Mol Biochem Parasitol. 1996;76:43–56.
40. Andrade-Neto VV, Cicco NN, Cunha-Junior EF, Canto-Cavalheiro MM, Atella
GC, Torres-Santos EC. The pharmacological inhibition of sterol biosynthesis
in Leishmania is counteracted by enhancement of LDL endocytosis.
Acta Trop. 2011;119:194–8.
41. Howe D, Heinzen RA. Coxiella burnetii inhabits a cholesterol-rich vacuole and
influences cellular cholesterol metabolism. Cell Microbiol. 2006;8(3):496–507.
42. Underwood KW, Andemariam B, McWilliams GL, Liscum L. Quantitative
analysis of hydrophobic amine inhibition of intracellular cholesterol
transport. J Lipid Res. 1996;37(7):1556–68.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Andrade-Neto et al. Parasites & Vectors  (2016) 9:183 Page 8 of 8
